Location: Home
  • search
  • go
  • Relate News
  • 4/5/2023China's Out-Licensing Boom Continued in February with Big Oncology Dru...
  • 4/5/2023WuXi STA Adds New Peptide Manufacturing Capacity and Large-Scale Conti...
  • 4/5/2023Pharmaron Plans UK Gene Therapy Expansion
  • 4/4/2023Pfizer, Meck Reportedly Slashed Prices of COVID-19 Pills in China
  • 4/1/2023China Further Intensifies Healthcare Cost Containment and Price Contro...
  • 3/31/2023Recent Executive Moves
  • 3/30/2023AstraZeneca, KYM Biosciences Complete Licensing Deal for Anticancer Dr...
  • 3/30/2023Apollomics Announces Closing of Business Combination and Listing on Na...
  • 3/30/2023IQVIA: Chinese Retail Pharmacy Sales up 5.2% in MAT Q4/2022
  • 3/30/2023Central Government Issues the Notice on Further Facilitating Medical E...
  • 3/30/2023Rxilient and Junshi form JV to Develop and Commercialize Toripalimab i...
  • 3/29/2023JPO Publicizes 8th VBP Tender Outcome, Which Cuts Average Price by 56%
  • 3/29/2023Investing in China's Healthcare Sector (China Briefing)
  • 3/27/2023BioNTech and Oncoc4 Sign Strategic Collaboration for Novel Checkpoint ...
  • 3/27/2023Hepalink's OncoVent Enter License Deal with Orient EuroPharma for Oreg...
  • 3/24/2023InvoX Pharma's F-star Announces 2nd Licence Deal with Takeda
  • 3/24/2023Pfizer Signs MOU with HCRC Aimed at Improving Rural Health in China
  • 3/24/2023New Report: Incidence of Moderate and Severe Ovarian Hyperstimulation ...
  • 3/23/2023Roche, CR Pharma Tie Up to Improve Access of Flu Drug Xofluza in Chna
  • 3/23/2023Chinese Government Issues the Opinions for Further Improving Healthcar...
  • 3/21/2023Therapeutic Antibody Licensing Deals in China: A 2022 End-Of-Year Summ...
  • 3/17/2023Upgrading Medtech Commercial Operations in China (McKinsey)
  • 3/17/2023CDE Solicits Comments on Draft Implementation Suggestions and Chinese ...
  • 3/17/2023Recent Executive Moves
  • 3/17/2023Jinyao Pharma Fined CNY 28M for Abuse of Market Dominance to Sell Chem...
  • 3/16/2023China Biotech Fundraising Up Sharply in February as Six Drugmakers Iss...
  • 3/15/2023Deloitte: 2023 China LSHC Investment and M&A Market Outlook
  • 3/15/2023NHSA Issues the Interim Measures for the Regulation of Unannounced Ins...
  • 3/14/2023HUTCHMED Announces Closing of Fruquintinib License to Takeda Outside C...
  • 3/14/2023Study: Alzheimer's Disease Awareness and Acceptance Is Low in China
  • Page:55/361 Total number of articles:10805: [First][<<] [53] [54] [55] [56] [57] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group